Evaluating the Stability of RNA-Seq Transcriptome Profiles and Drug-Induced Immune-Related Expression Changes in Whole Blood

• John F. Bowyer ,

  * E-mail: john.bowyer@fda.hhs.gov

  Affiliation Division of Neurotoxicology, National Center for Toxicological Research, United States Food and Drug Administration, Jefferson, Arkansas, United States of America

  ⨯
• Karen M. Tranter,

  Affiliation Division of Neurotoxicology, National Center for Toxicological Research, United States Food and Drug Administration, Jefferson, Arkansas, United States of America

  ⨯
• Joseph P. Hanig,

  Affiliation Center for Drug Evaluation and Research, United States Food and Drug Administration, Silver Spring, Maryland, United States of America

  ⨯
• Nathaniel M. Crabtree,

  Affiliation Division of Neurotoxicology, National Center for Toxicological Research, United States Food and Drug Administration, Jefferson, Arkansas, United States of America

  ⨯
• Robert P. Schleimer,

  Affiliation Division of Allergy and Immunology, Northwestern Feinberg School of Medicine, Chicago, Illinois, United States of America

  ⨯
• Nysia I. George

  Affiliation Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, United States Food and Drug Administration, Jefferson, Arkansas, United States of America

  ⨯